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SUMMARY
Background
Determining a relationship between specific histological parameters in
cirrhosis and hepatic venous pressure gradient can be used to subclas-
sify cirrhosis.
Aim
To determine the relationship between hepatic venous pressure gradient
and specific histological parameters in cirrhosis.
Methods
Forty-seven patients (mean age: 46.2  13.6 years; 36 male) with
biopsy-proven cirrhosis and hepatic venous pressure gradient measure-
ments within 1 month of biopsy were studied. The following histologi-
cal parameters were scored semiquantitatively: nodule size, loss of
portal tracts and central veins, portal inflammation, periportal inflam-
mation, bile duct proliferation, lobular inflammation, ballooning, fatty
change, cholestasis and septal thickness.
Results
On multiple ordinal regression analysis, small nodule size (odds ratio:
21.0; 95% confidence interval: 2.1–208.2, P = 0.009) and thick septa (OR:
42.6; CI: 2.3–783.7, P = 0.011) were significantly associated with the
presence of clinically significant portal hypertension. A score was
assigned to each of the two parameters (nodule size: large = 1, med-
ium = 2, small = 3 and septal thickness: thin = 1, medium = 2, thick =
3). Two subcategories were devised based on the composite score: cate-
gory A (n = 12): score 1–3 and category B (n = 35): score 4–6. On ordinal
regression, subcategory B (OR: 15.5; CI: 3.3–74.2, P = 0.001) was signifi-
cantly associated with clinically significant portal hypertension.
Conclusion
Small nodularity and thick septa are independent predictors of the pres-
ence of clinically significant portal hypertension.
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INTRODUCTION
Cirrhosis is defined histologically by the presence of
regenerative nodules surrounded by fibrous tissue. This
architectural distortion leads to increased intrahepatic
resistance that in turn leads to portal hypertension.
Complications of cirrhosis, including oesophageal vari-
ces and ascites, develop once portal pressure reaches a
threshold level of 10–12 mmHg, as assessed by the
hepatic venous pressure gradient (HVPG).1–3 Cirrhosis
denotes the most severe stage of liver fibrosis. How-
ever, in cirrhosis, there may be certain histological
features indicative of more severe disease. The most
direct and accessible evaluation of portal hypertensive
syndrome is performed by measuring the HVPG, which
has been validated as an indicator of the degree of
portal pressure in cirrhosis.1 HVPG reflects the interac-
tion between hepatic vascular resistance and blood
flow and, as such, is thought to indicate disease sever-
ity closely. The prognostic value of HVPG has been
demonstrated in different settings associated with
chronic liver disease and has been shown to correlate
with survival, decompensation and development of
collaterals.1, 4–6
Defining a relationship between specific histological
parameters in cirrhosis and HVPG could help subclas-
sify cirrhosis according to its ‘severity’ as measured by
HVPG. Recently, Nagula et al. described a subclassifi-
cation of histological cirrhosis on the basis of severity
of portal hypertension that consists of a combination
of nodule size and septal thickness, with small nodu-
larity and thick septa being independent predictors of
the presence of clinically significant portal hyperten-
sion (CSPH).7 These findings need further evaluation
and validation.
This study was undertaken to determine the rela-
tionship between portal pressure, as determined by the
HVPG and specific histological parameters in cirrhosis
and to propose a histological subclassification of cir-
rhosis.
PATIENT AND METHODS
Patients
Patients who had a liver biopsy specimen (obtained
via a transjugular or percutaneous approach) showing
a diagnosis of cirrhosis, and HVPG performed within
1 month of each other were included in the study. All
specimens were characterized by a length of ‡1.0 cm
and width of ‡1.2 mm. In fragmented biopsies, the
total length was estimated by adding maximum
dimensions of each individual fragment.
Histological assessment
Individual biopsy specimens were scored with the use
of the Knodell index, which grades the histological
activity of hepatitis on a scale from 0 to 18, with
higher scores indicating more severe abnormalities.8
Table 1. Morphological assessment of liver biopsies
Histological parameter Range Scale
Nodularity
Small nodules Nodule size is comparable to width of needle biopsy specimen
Mixed nodules Presence of both small and large nodules (The presence of even
one small nodule would lead to a ‘mixed’ classification)
Large nodules Nodule size larger than biopsy width
Portal tracts lost 0–4 0 = absent, 1 = 1–25%, 2 = 26–50%, 3 = 51–75%, 4 = 76–100%
Central veins lost 0–4 0 = absent, 1 = 1–25%, 2 = 26–50%, 3 = 51–75%, 4 = 76–100%
Portal inflammation 0–3 0 = absent, 1 = mild, 2 = moderate, 3 = severe
Periportal inflammation 0–3 0 = absent, 1 = mild, 2 = moderate, 3 = severe
Bile duct proliferation 0–2 0 = absent, 1 = present, normal; 2 = present, abnormal, increased
Lobular inflammation 0–3 0 = absent, 1 = mild, 2 = moderate, 3 = severe
Ballooning 0–2 0 = absent, 1 = present, normal; 2 = present, abnormal, increased
Fatty change 0–4 0 = absent, 1 = 1–25%, 2 = 26–50%, 3 = 51–75%, 4 = 76–100%
Cholestasis 0–2 0 = absent, 1 = present, normal; 2 = present, abnormal, increased
Septal thickness 0–3 0 = absent, 1 = thin, 2 = medium, 3 = thick (Thickness of the
predominant type of septae in each specimen)
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The overall Knodell score [Histological Activity Index
(HAI)] is the sum of the scores for periportal bridging
necrosis (0–10), intralobular degeneration and focal
necrosis (0–4), and portal inflammation (0–4). Staging
was according to Batts and Ludwig staging,9 where F1
is portal expansion, F2 is portal septae with or without
portal–portal bridging fibrosis, F3 is portal–central
bridging fibrosis and F4 is cirrhosis.
Table 2. Baseline clinical and laboratory parameters of
the study population
Variable n = 47
Age (year; mean  s.d.) 46.2  13.6
Male gender, n (%) 36 (77)
Bilirubin (mg ⁄ dL; mean  s.d.) 1.8  1.4
Albumin (g ⁄ dL; mean  s.d.) 3.5  0.7
Platelet count [Lac ⁄ cumm; median
(range)]
1.4 (0.35–3.2)
AST [U ⁄ L; median (range)] 74 (20–400)
ALT [U ⁄ L; median (range)] 60 (14–285)
PT prolongation [s; median (range)] 3.7 (0–25)
Child status, n (%)
A 18 (38)
B 21 (45)
C 8 (17)
Oesophageal varices, n (%)
Absent 2 (4)
Gr 1 8 (17)
Gr 2 24 (51)
Gr 3 8 (17)
Gr 4 4 (11)
GOV, n (%) 8 (17)
IGV, n (%) 1 (2)
PHG, n (%)
Mild 15 (32)
Severe 1 (2)
Variceal bleeding history, n (%) 11 (23)
Percutaneous liver biopsy 27
Transjugular liver biopsy 20
Aetiology of cirrhosis, n (%)
Hepatitis B 21 (45)
Hepatitis C 9 (19)
Alcohol 1 (2)
Hepatitis B plus C 3 (6)
Hepatitis B plus alcohol 2 (4)
Cryptogenic 11 (23)
HVPG (mmHg)
Median (range) 13 (7–33)
‡10, n (%) 31 (66)
GOV, gastro-oesophageal varices; IGV, isolated gastric
varices; PHG, portal hypertensive gastropathy; HVPG,
hepatic venous pressure gradient.
Table 3. Median hepatic venous pressure gradient (HVPG)
for each histological parameter (n = 47)
Histological
parameter
HVPG [mmHg;
median (range)] P-value*
Nodularity
Small (n = 15) 22 (11–33) 0.001
Mixed (n = 18) 12.5 (8–24)
Large (n = 14) 9 (7–18)
Portal tracts lost
0 (n = 10) 11.5 (8.5–18) 0.326
1 (n = 3) 13 (11–33)
2 (n = 6) 13.7 (9–30)
3 (n = 11) 12 (7–24)
4 (n = 17) 18 (8–28)
Central veins lost
0 (n = 3) 9 (8–11) 0.643
1 (n = 5) 12 (8–23)
2 (n = 4) 19 (9–22)
3 (n = 12) 12 (8–33)
4 (n = 23) 14 (7–30)
Portal inflammation
0 (n = 0) – 0.330
1 (n = 26) 12 (7–33)
2 (n = 11) 20 (9–23)
3 (n = 10) 13 (8–30)
Periportal inflammation
0 (n = 4) 8.5 (7–28) 0.053
1 (n = 15) 9 (8–33)
2 (n = 11) 20 (9–28)
3 (n = 17) 13 (8–23)
Bile duct proliferation
0 (n = 16) 10.5 (8–26) 0.371
1 (n = 23) 12 (7–30)
2 (n = 8) 20.5 (9–33)
Lobular inflammation
0 (n = 3) 24 (13.5–26) 0.112
1 (n = 19) 12 (8–33)
2 (n = 19) 13 (7–23)
3 (n = 6) 13 (9–23)
Ballooning
0 (n = 4) 11.2 (8–20) 0.182
1 (n = 24) 12.5 (7–33)
2 (n = 19) 14 (9–28)
Fatty change
0 (n = 32) 11.5 (7–33) 0.460
1 (n = 12) 20 (8–28)
2 (n = 3) 20 (18–28)
3 (n = 0) –
4 (n = 0) –
Cholestasis
0 (n = 26) 11 (8–23) 0.140
1 (n = 11) 17 (7–33)
2 (n = 10) 18 (8–30)
HISTOLOGICAL SUBCLASSIF ICAT ION OF CIRRHOSIS AND HEPAT IC VENOUS PRESSURE 773
ª 2008 The Authors, Aliment Pharmacol Ther 27, 771–779
Journal compilation ª 2008 Blackwell Publishing Ltd
Slides of each biopsy were reviewed by two patholo-
gists (PS and AR) who were blinded to the results of
HVPG measurements and they gave a final score to each
of the components. Discrepancies in scoring of various
lesions were few and minor; they were then reviewed by
both pathologists together to arrive at a consensus.
The biopsies were evaluated for the parameters
given in Table 1. In case of heterogeneous pattern of
sinusoidal fibrosis, the worst pattern was scored. For
septal thickness, the thickness of the predominant type
of septae in each specimen was scored. Regarding
nodule size, the presence of even one small nodule
would lead to a ‘mixed’ classification. Regarding loss
of portal tracts and portal veins, we anticipated 4–6
portal tracts and central veins per centimetre of core
needle biopsy, therefore, the absence of identifiable
portal tracts in the liver biopsy was scored as ‘4’ (max-
imal abnormality), while their presence, as expected
for a normal biopsy (at least 4 portal tracts ⁄ cm), was
scored as ‘0’. Similarly, a central vein is expected for
each lobule in a normal biopsy and by comparison in
each nodule of a cirrhotic liver. The loss of central
veins was also subjectively scored on a 0–4 scale.
Absence of identifiable central veins in all cirrhotic
nodules was scored as ‘4’, while their presence in each
cirrhotic nodule was scored as ‘0’.
Hepatic venous pressure gradient measurements
After an overnight fast, HVPG measurement was carried
out using standard procedure. Briefly, under local
anaesthesia and in supine position, a venous introducer
was placed into the right femoral vein by Seldinger
technique. Under fluoroscopic guidance, a 7F balloon-
tipped Swan Ganz Catheter (Boston Scientific, MA,
USA) was introduced into the main right hepatic vein.
Free hepatic venous pressure and wedged (occluded)
hepatic venous pressure were measured using Nihon
Kohden (Tokyo, Japan) haemodynamic monitor with
pressure transducers. Measurements were made in tripli-
cate, and the mean of three readings was taken in every
case. If there was a difference of more than 1 mmHg
between the readings, all the readings were
repeated.10, 11 Patients were categorized as having CSPH
if HVPG was ‡10 mmHg.1, 3, 4
Table 3. (Continued)
Histological
parameter
HVPG [mmHg;
median (range)] P-value*
Septal thickness
0 (n = 0) – 0.001
1 (n = 8) 9 (8–12)
2 (n = 21) 11 (7–18)
3 (n = 18) 22 (12–33)
* One-way ANOVA.
P < 0.001
Large Mixed Small
Nodule size
10.00
15.00
20.00
25.00
30.00 P < 0.001
Thin Medium Thick
Septal thickness
10.00
15.00
20.00
25.00
30.00
H
VP
G
 ( m
mH
g)
H
VP
G
 (m
mH
g)
Figure 1. Distribution of hepatic venous pressure gradient (HVPG) according to nodule size and septal thickness, showing
median HVPG, 25–75th percentile box and complete range of measurements.
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Statistical analysis
The unpaired Student’s t-test was applied for compari-
sons of normally distributed variables. The statistical
significance of inter-group differences, for non-normal
distributed data, was evaluated by means of Mann–
Whitney U-tests. Chi-squared test (Yates correction as
required) was used for comparison of categorical vari-
ables. One-way ANOVA was used to test for differences
among three or more groups. Spearman rank correla-
tion coefficient was used to find correlations between
histological parameters and HVPG. Ordinal regression
was used to identify the histological factors that
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Table 5. Histological correlates of HVPG in cirrhotics
Parameter
Spearman’s
correlation
Significance
(two-tailed)
HAI )0.04 0.77
Nodularity )0.76 <0.001
Portal tracts lost 0.15 0.31
Central veins lost 0.20 0.18
Portal inflammation 0.15 0.32
Periportal inflammation 0.17 0.24
Bile duct proliferation 0.33 0.02
Lobular inflammation )0.14 0.34
Ballooning 0.17 0.26
Fatty change 0.25 0.09
Cholestasis 0.29 0.06
Septal thickness 0.81 <0.001
HVPG, hepatic venous pressure gradient.
Table 6. Ordinal regression for prediction of clinically
significant portal hypertension from histological
parameters
Parameter OR 95% CI Significance
Nodularity
Small 21.0 2.1–208.2 0.009
Mixed 15.8 2.0–122.6 0.008
Large 1
Septal thickness
Thick 42.8 2.3–783.7 0.011
Medium 17.3 1.2–252.7 0.037
Thin 1
Bile duct proliferation
2 2.4 0.1–53.6 0.578
1 2.2 0.3–15.5 0.415
0 1
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correlated with the presence of CSPH. P-values <0.05
were considered statistically significant.
RESULTS
In the period between May 1994 and July 2007, 158
patients with chronic liver disease had a liver biopsy
performed within 1 month of HVPG measurement.
Four patients were excluded for reasons of fragmented,
small specimens. Of the 154 remaining patients, 107
patients had earlier stages of chronic liver disease
(precirrhotic). Histological cirrhosis (stage 4) was pres-
ent in the liver biopsies of 47 patients who were
included in the present analysis. These patients were
subjected to the haemodynamic study to obtain a basal
assessment of portal pressure before enrolling in a pri-
mary (n = 6), secondary (n = 11) or early primary pro-
phylaxis (n = 28) protocols for variceal bleeding or for
diagnostic purposes (n = 2) to exclude noncirrhotic
causes of portal hypertension.
Table 2 shows the baseline clinical and laboratory
parameters of the patients. Hepatitis B was the most
common aetiological factor present in 21 (45%) cases.
The median HVPG was 13.0 mmHg with a range of
7–33; 31 patients (66%) had CSPH.
Correlation between HVPG and histological
parameters
Table 3 shows the HVPG values for each histological
parameter. HVPG was statistically different among the
subcategories of nodule size (P < 0.001), and septal
thickness (P < 0.001) (Figure 1). Table 4 shows the dis-
tribution of histological parameters according to the
presence or absence of CSPH. Nodule size and septal
thickness were found to be significantly different
between patients with and without CSPH. Table 5
shows the histological correlates of HVPG in cirrhotics.
There was a significant correlation between HVPG and
nodule size, septal thickness and bile duct prolifera-
tion. These three factors were entered into a multiple
ordinal regression analysis with CSPH as the depen-
dent variable (Table 6). Small nodule size and thick
septa were significantly associated with the presence
of CSPH. Representative micrographs of nodule size
and septal thickness are illustrated in Figures 2 and 3.
For subcategorizing the histological cirrhosis a com-
posite score was developed. A score was assigned to
each of the two parameters (nodule size: large = 1,
medium = 2, small = 3 and septal thickness: thin = 1,
medium = 2, thick = 3). Two subcategories of histolog-
(a) (b)
(c)
Figure 2. Representative slides
(trichrome stain) demonstrating
different septal thicknesses: thin
(a), intermediate (b) and thick (c).
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ical cirrhosis were devised based on the composite
score calculated by adding the score assigned to each
of the two parameters: Category A: score 1–3 and Cat-
egory B: score 4–6. Median (range) of HVPG was 9 (7–
17) and 17.5 (8–33) mmHg (P < 0.001) in subcategory
A and B respectively. Subcategory was analysed in
ordinal regression as a predictor of CSPH and it was
found that subcategory B [odds ratio (OR): 15.5; 95%
confidence interval (CI): 3.3–74.2, P = 0.001] was sig-
nificantly associated with the presence of CSPH.
DISCUSSION
The most advanced stage of liver fibrosis is the cir-
rhotic stage. As most complications of cirrhosis are
secondary to portal hypertension, HVPG has been
found to be of major prognostic significance. A
threshold level of 10 mmHg has been identified as a
predictor of the development of complications of cir-
rhosis (varices, variceal haemorrhage and ascites) and
death.10, 12 We found that septal thickness and nodule
size were the two independent predictors of the pres-
ence of CSPH. Similar findings were also reported in
an earlier study.7 These findings are consistent with
the pathophysiology of portal hypertension. The dis-
ease progression from chronic hepatitis to cirrhosis of
the liver is associated with an increase in portal pres-
sure.13, 14 These factors responsible for increase in por-
tal pressure include major angio-architectural
modifications involving neo-angiogenesis and the
presence of cell types undergoing active contraction in
response to an intrahepatic predominance of vasocon-
strictor stimuli.15, 16 As a result, the progressive rise in
portal pressure represents a reliable indicator of the
tissue changes typical of the cirrhotic liver. Thick sep-
tae exert greater obstruction to portal flow and leads
to higher HVPG. Small nodule size is also indicative
of greater architectural distortion and increased intra-
hepatic resistance.7
Suggestions for subclassification of histological cir-
rhosis were made earlier;17 this was based on the char-
acteristics of fibrous septae. In patients with alcoholic
liver disease, a positive correlation has been identified
between intrahepatic pressure and hepatocyte size and
collagen in the space of Disse.18 Other studies have
shown progressive increases in HVPG with increasing
severity of liver disease (normal, chronic hepatitis,
precirrhosis and cirrhosis).12, 19–21 However, in a study
(a) (b)
(c)
Figure 3. Representative slides
(trichrome stain) demonstrating
different nodule size: small (a),
mixed (b) and large (c).
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no relevant correlation could be found between HVPG
and any histological parameter.22 Another study,
found a negative correlation between HVPG and the
portal spaces not involved in the process of bridging
fibrosis.23 Recently, Nagula et al. described a subclas-
sification of histological cirrhosis based on the severity
of portal hypertension that consists of a combination
of nodule size and septal thickness, with small nodu-
larity and thick septa being independent predictors of
the presence of CSPH.7 This conclusion is identical to
the conclusion of this study but the study population
is different. In the study by Nagula et al., majority of
the patients had alcohol as the aetiology of cirrhosis,
whereas in this study, hepatitis B virus was the aetio-
logical factor in the majority of the patients. In addi-
tion, we have proposed a scoring system on the basis
of nodule size and septal thickness.
In our study, only one patient had pure alcoholic
cirrhosis and so our findings may not be applicable to
that subpopulation of cirrhosis.
We subcategorized histological cirrhosis into Cate-
gory A and B on the basis of a composite score
derived from nodule size and septal thickness and
found that the categorization was a significant predic-
tor for the presence of CSPH. Follow-up studies exam-
ining serial biopsies and HVPG measurements need to
be undertaken in a larger population to validate the
proposed scoring system, which also needs to be veri-
fied in larger sample size of patients belonging to dif-
ferent aetiological categories.
In conclusion, small nodularity and thick septa on
histology are independent predictors of the presence of
CSPH. The histological subclassification of cirrhosis
based on a combination of nodule size and septal
thickness needs further validation.
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